Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EscharEx for Debridement of Venous Leg Ulcers
NCT03588130Phase 2Completed
- Sponsor
- MediWound
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of EscharEx in venous leg ulcer (VLU), sponsored by MediWound. Started Dec 2019; status: completed.
02
Drugs
EscharEx
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT03588130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03588130.